By Elias Schisgall

Shares of Sight Sciences fell after the company said it expects its revenue in 2025 may have fallen year-over-year.

Shares were down 9.9% to $6.68 on Tuesday afternoon. The stock has doubled in value in the past year.

The eyecare technology company said Tuesday that it expects to report full-year revenue between $77.3 million and $77.4 million. At the midpoint, that would represent a 3% decrease compared to the previous year.

For the current fourth quarter, the company said it expects to report revenue between $20.3 million and $20.4 million, representing a 7% year-over-year increase at the midpoint.

Much of the full-year revenue decline was driven by the company's dry eye segment. Full-year revenue from that segment is expected to fall to about $1.6 million, compared with $4 million a year earlier.

Analysts surveyed by FactSet were expecting the company to report $20.2 million in revenue for the quarter and $77.1 million for the year.

Write to Elias Schisgall at elias.schisgall@wsj.com

(END) Dow Jones Newswires

January 13, 2026 14:45 ET (19:45 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.